Saltar al contenido
Black Friday — 30% OFFEnvío gratis en pedidos desde 99 €
  1. Inicio
  2. Salud cognitiva y nootrópicos
  3. Sunifiram – powder, 10 grams
Salud cognitiva

Sunifiram – powder, 10 grams

Sunifiram (DM-235) is a synthetic pyrrolidinone-derived compound structurally distinct from the classical racetam family despite sharing a related core scaffold, investigated for proposed positive allosteric modulation of AMPA-type glutamate receptors.

Presentación: Sunifiram – powder, 10 grams.

Envase ilustrativo generado con IA.

El precio original era: 34,99 €.El precio actual es: 24,49 €.

No disponible actualmente en España

Consulta a un asesor
Un asesor se pone en contacto contigo y la farmacia asociada comprueba si es posible continuar y cómo. Puede ser necesaria una receta válida o una evaluación a través de un servicio de telemedicina autorizado.
  • Farmacia asociada
  • Atención personalizada
  • Entrega discreta
  • Presentación
    Sunifiram – powder, 10 grams

Envío y entrega

  • Envío habitual en 24 horas tras confirmarse el pago.
  • USPS Regular Shipping · 11,95 € · Aprox. 3–5 días laborables
  • FedEx 2 Days Delivery · 28,99 € · Aprox. 2 días laborables
  • FedEx Overnight Delivery · 40,99 € · Aprox. 1 día laborable

Solo para investigación de laboratorio.

No apto para uso humano o veterinario.

Composición y detalles del producto

Descripción

Sunifiram (DM-235) is a synthetic pyrrolidinone-derived compound structurally distinct from the classical racetam family despite sharing a related core scaffold, investigated for proposed positive allosteric modulation of AMPA-type glutamate receptors. Research interest centers on its reported high in vitro potency relative to piracetam-class compounds at substantially lower concentrations.

Research applications include AMPA receptor potentiator pharmacology, glutamatergic signalling research, and structure-activity comparison within the pyrrolidinone-derivative compound series.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Propiedades

Chemical Formula C14H18N2O2
Synonyms DM-235
Molar Mass 246.304 g/mol
CAS Number 314728-85-3
PubChem CID 4223812
Total Compound Content 10 grams
Shelf Life 36 months

Investigación

Sunifiram is studied as a positive allosteric modulator candidate at AMPA-type ionotropic glutamate receptors, a mechanism investigated using patch-clamp electrophysiology to characterise changes in AMPA receptor-mediated current amplitude and desensitization kinetics in the presence of the compound. Comparative potency studies position sunifiram within structure-activity relationship research examining how its specific pyrrolidinone-derived substituent pattern relates to reported nanomolar-range activity, in contrast to the typically higher concentrations required for classical racetam-family compounds in similar assay systems. Independently third-party HPLC-tested; COA available per batch.

FAQ

How does sunifiram’s structure relate to and differ from the classical racetam compound family?

Sunifiram shares a pyrrolidinone-derived structural lineage conceptually related to the racetam family but is synthesized via a distinct chemical route and carries substituents not present in piracetam, oxiracetam, or other classical racetam-family compounds. This structural distinction is the basis for research comparing sunifiram’s receptor-binding and functional potency profile against established racetam compounds, particularly given reports of substantially different potency ranges between the two groups in similar assay systems.

What electrophysiological methods characterize sunifiram’s proposed AMPA receptor potentiating activity?

Patch-clamp electrophysiology in cultured neurons, brain slice preparations, or heterologous expression systems is the standard method for characterising sunifiram’s effects on AMPA receptor-mediated currents, with key readouts including peak current amplitude, desensitization rate, and deactivation kinetics in the presence versus absence of the compound. These functional measurements are used alongside receptor-binding assays to determine whether sunifiram acts at an allosteric site distinct from the glutamate orthosteric binding site, consistent with a positive allosteric modulator mechanism.

What concentration ranges are typically used in research characterizing sunifiram’s in vitro potency?

Reports of sunifiram’s in vitro activity describe substantially lower effective concentrations than those required for classical racetam-family compounds in comparable assay systems, prompting researchers to use nanomolar-to-low-micromolar concentration ranges when establishing dose-response curves for sunifiram, in contrast to the micromolar-to-millimolar ranges typically required for piracetam-class compounds. Researchers should empirically establish the relevant concentration range for their specific assay system and cell model rather than assuming direct potency transfer from other reported studies.